You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

~ Buy the LOKELMA (sodium zirconium cyclosilicate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR LOKELMA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for lokelma

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04063930 ↗	The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia	Recruiting	AstraZeneca	Phase 4	2019-10-01	To investigate whether concomitant treatment with Lokelma can improve the efficacy of standard blockade of the renin-angiotensin system in patients with type 2 diabetes, diabetic nephropathy and hyperkalemia.
NCT04063930 ↗	The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia	Recruiting	Zealand University Hospital	Phase 4	2019-10-01	To investigate whether concomitant treatment with Lokelma can improve the efficacy of standard blockade of the renin-angiotensin system in patients with type 2 diabetes, diabetic nephropathy and hyperkalemia.
NCT04063930 ↗	The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia	Recruiting	Steno Diabetes Center Copenhagen	Phase 4	2019-10-01	To investigate whether concomitant treatment with Lokelma can improve the efficacy of standard blockade of the renin-angiotensin system in patients with type 2 diabetes, diabetic nephropathy and hyperkalemia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for lokelma

Condition Name

Chart
Table

Condition Name for lokelma
Intervention	Trials
Hyperkalemia	4
ACE Inhibitor Induced Hyperkalaemia	1
Oral Potassium Binders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for lokelma
Intervention	Trials
Hyperkalemia	7
Renal Insufficiency, Chronic	2
Kidney Diseases	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for lokelma

Trials by Country

Map
Table

Trials by Country for lokelma
Location	Trials
United States	6
United Kingdom	3
Italy	1
Denmark	1
Germany	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for lokelma
Location	Trials
California	2
North Carolina	1
Missouri	1
Indiana	1
Georgia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for lokelma

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for lokelma
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for lokelma
Clinical Trial Phase	Trials
Recruiting	5
Not yet recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for lokelma

Sponsor Name

Chart
Table

Sponsor Name for lokelma
Sponsor	Trials
AstraZeneca	4
Zealand University Hospital	1
Steno Diabetes Center Copenhagen	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for lokelma
Sponsor	Trials
Other	8
Industry	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.